Humana Stock Price, News & Analysis (NYSE:HUM)

$253.64 3.03 (1.21 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$253.64
Today's Range$250.00 - $257.24
52-Week Range$186.25 - $264.56
Volume2.02 million shs
Average Volume1.38 million shs
Market Capitalization$36.61 billion
P/E Ratio21.86
Dividend Yield0.62%
Beta0.88

About Humana (NYSE:HUM)

Humana logoHumana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Managed Health Care
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:HUM
CUSIP44485910
Phone502-580-1000

Debt

Debt-to-Equity Ratio0.35%
Current Ratio1.61%
Quick Ratio1.61%

Price-To-Earnings

Trailing P/E Ratio21.86
Forward P/E Ratio21.81
P/E Growth1.76

Sales & Book Value

Annual Sales$54.38 billion
Price / Sales0.67
Cash Flow$12.68 per share
Price / Cash20.01
Book Value$71.66 per share
Price / Book3.54

Profitability

Trailing EPS$12.71
Net Income$614 million
Net Margins3.49%
Return on Equity15.99%
Return on Assets5.63%

Miscellaneous

Employees51,600
Outstanding Shares142,860,000

Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, November 2nd. Stockholders of record on Friday, December 29th will be given a dividend of $0.40 per share on Friday, January 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.63%. The ex-dividend date of this dividend is Thursday, December 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana declared that its board has initiated a stock buyback program on Friday, December 15th 2017, which permits the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's leadership believes its shares are undervalued.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) posted its quarterly earnings results on Wednesday, November, 8th. The insurance provider reported $3.39 earnings per share for the quarter, beating analysts' consensus estimates of $3.27 by $0.12. The insurance provider earned $13.28 billion during the quarter, compared to the consensus estimate of $13.41 billion. Humana had a net margin of 3.49% and a return on equity of 15.99%. The firm's revenue was down 3.0% on a year-over-year basis. During the same period last year, the firm earned $3.18 EPS. View Humana's Earnings History.

When will Humana make its next earnings announcement?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, February, 14th 2018. View Earnings Estimates for Humana.

Where is Humana's stock going? Where will Humana's stock price be in 2017?

19 brokerages have issued 12 month target prices for Humana's shares. Their predictions range from $210.00 to $300.00. On average, they expect Humana's stock price to reach $255.72 in the next year. View Analyst Ratings for Humana.

What are Wall Street analysts saying about Humana stock?

Here are some recent quotes from research analysts about Humana stock:

  • 1. According to Zacks Investment Research, "Humana is well poised to grow on its strong government business. Its top-line has been witnessing an uptrend from past many years. Sufficient generation of cash flow has helped the company take up several capital deployment initiatives aimed at enhancing shareholders’ value. Humana’s sound balance sheet and disciplined capital management remains a positive.  Following its strong second-quarter 2017 results, it raised its 2017 adjusted EPS guidance. The company has also seen the Zacks Consensus Estimate for the current year earnings being revised upward in last 30 days. Although the shares have performed in line with the industry in a year's time, its strong fundamentals are likely to help the stock in gaining momentum going forward. However, the company's individual commercial business has remained a drag over past few years. The company will release third quarter results on Nov 8, 2017." (10/17/2017)
  • 2. Cantor Fitzgerald analysts commented, "We are transferring coverage of Humana (HUM) and rate the shares at Neutral; our 12-month DCF-based price target is $186. The shares trade 6% above our price target, probably due in part to continued speculation that HUM remains a takeover candidate. We believe there is a low probability that AET will successfully appeal a recent court decision which ruled against the merger (if it even decides to appeal the decision). We assign a low probability that HUM will be acquired, at least in the short term. HUM's losses relating to the Affordable Care Act will shrink in 2017 and 2018. Medicare continues to perform well, recognizing that HUM 2018 MA reimbursement could be impacted by a reduction in its star ratings. With about 6% downside to our target price, our rating is Neutral." (2/6/2017)

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:

  • Kurt J. Hilzinger, Independent Chairman of the Board (Age 57)
  • Bruce D. Broussard, President, Chief Executive Officer, Director (Age 54)
  • Brian A. Kane, Chief Financial Officer, Senior Vice President (Age 44)
  • Timothy S. Huval, Chief Human Resource Officer, Senior Vice President (Age 50)
  • Brian P. LeClaire, Senior Vice President, Chief Information Officer (Age 56)
  • Sam Deshpande, Senior Vice President, Chief Risk Officer
  • Christopher M. Todoroff, Senior Vice President, General Counsel (Age 54)
  • Roy A. Beveridge M.D., Senior Vice President, Chief Medical Officer (Age 59)
  • Jody L. Bilney, Senior Vice President, Chief Consumer Officer (Age 55)
  • Christopher H. Hunter, Senior Vice President, Chief Strategy Officer (Age 48)

Who owns Humana stock?

Humana's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Janus Henderson Group PLC (1.91%), Evercore Trust Company N.A. (1.42%), Bank of New York Mellon Corp (1.15%), Wells Fargo & Company MN (1.14%), Dimensional Fund Advisors LP (1.11%) and Ameriprise Financial Inc. (1.01%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Who sold Humana stock? Who is selling Humana stock?

Humana's stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, OZ Management LP, SG Americas Securities LLC, Amundi Pioneer Asset Management Inc., Russell Investments Group Ltd., Evercore Trust Company N.A., Columbus Circle Investors and Asset Management One Co. Ltd.. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.

Who bought Humana stock? Who is buying Humana stock?

Humana's stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Old Mutual Global Investors UK Ltd., APG Asset Management N.V., PGGM Investments, Caisse DE Depot ET Placement DU Quebec, Wells Fargo & Company MN, Ameriprise Financial Inc. and American Century Companies Inc.. View Insider Buying and Selling for Humana.

How do I buy Humana stock?

Shares of Humana can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of Humana stock can currently be purchased for approximately $253.64.

How big of a company is Humana?

Humana has a market capitalization of $36.61 billion and generates $54.38 billion in revenue each year. The insurance provider earns $614 million in net income (profit) each year or $12.71 on an earnings per share basis. Humana employs 51,600 workers across the globe.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.


MarketBeat Community Rating for Humana (HUM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  562 (Vote Outperform)
Underperform Votes:  658 (Vote Underperform)
Total Votes:  1,220
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Humana (NYSE:HUM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.572.572.652.60
Ratings Breakdown: 0 Sell Rating(s)
9 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $245.95$245.14$237.20$221.39
Price Target Upside: 3.41% downside0.31% upside4.11% downside3.85% downside

Humana (NYSE:HUM) Consensus Price Target History

Price Target History for Humana (NYSE:HUM)

Humana (NYSE:HUM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/13/2017CowenReiterated RatingBuy$285.00LowView Rating Details
12/5/2017Cantor FitzgeraldReiterated RatingHold$230.00LowView Rating Details
11/10/2017Credit Suisse GroupLower Price TargetNeutral$256.00 -> $246.00N/AView Rating Details
11/10/2017BMO Capital MarketsBoost Price TargetOutperform$290.00 -> $300.00N/AView Rating Details
11/9/2017Morgan StanleyLower Price TargetOverweight$276.00 -> $270.00N/AView Rating Details
11/9/2017Royal Bank of CanadaReiterated RatingSector Perform -> Sector Perform$245.00 -> $242.00N/AView Rating Details
10/13/2017Jefferies GroupReiterated RatingHold$257.00N/AView Rating Details
10/9/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$253.00N/AView Rating Details
8/7/2017Deutsche BankBoost Price TargetHold$234.00 -> $243.00LowView Rating Details
8/3/2017OppenheimerBoost Price TargetOutperform$236.00 -> $255.00MediumView Rating Details
8/3/2017Piper Jaffray CompaniesBoost Price TargetOverweight$280.00HighView Rating Details
7/14/2017Bank of AmericaBoost Price TargetBuy$270.00 -> $275.00LowView Rating Details
6/28/2017CitigroupInitiated CoverageBuy -> Buy$275.00MediumView Rating Details
6/9/2017ArgusUpgradeHold -> Buy$260.00LowView Rating Details
5/30/2017Leerink SwannBoost Price TargetOutperform$250.00 -> $265.00LowView Rating Details
4/25/2017Evercore ISIReiterated RatingOutperform$240.00LowView Rating Details
3/30/2017CIBCReiterated RatingOutperformLowView Rating Details
1/24/2017Stifel NicolausDowngradeBuy -> Hold$214.00 -> $210.00N/AView Rating Details
1/9/2017BarclaysReiterated RatingHold$217.00N/AView Rating Details
12/4/2016Susquehanna BancsharesReiterated RatingNeutral$180.00 -> $200.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMkt Perform$220.00 -> $170.00N/AView Rating Details
7/21/2016Wolfe ResearchUpgradeOutperform$192.00N/AView Rating Details
(Data available from 12/15/2015 forward)

Earnings

Humana (NYSE:HUM) Earnings History and Estimates Chart

Earnings by Quarter for Humana (NYSE:HUM)

Humana (NYSE HUM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/8/2018$2.02N/AView Earnings Details
11/8/2017Q3 2017$3.27$3.39$13.41 billion$13.28 billionViewN/AView Earnings Details
8/2/2017Q2 2017$3.08$3.49$13.61 billion$13.53 billionViewListenView Earnings Details
5/3/2017Q1 2017$2.55$2.75$13.61 billion$13.76 billionViewN/AView Earnings Details
2/8/2017Q416$2.05$2.09$13.55 billion$12.88 billionViewN/AView Earnings Details
11/4/2016Q316$3.09$3.18$13.41 billion$13.69 billionViewN/AView Earnings Details
8/3/2016Q216$2.23$2.30$13.59 billion$14.00 billionViewN/AView Earnings Details
5/4/2016Q1$1.81$1.86$13.80 billion$13.80 billionViewN/AView Earnings Details
2/10/2016Q415$1.45$1.45$13.51 billion$13.40 millionViewN/AView Earnings Details
11/6/2015Q315$2.13$2.16$13.64 billion$13.36 billionViewN/AView Earnings Details
7/29/2015Q215$1.63$1.67$13.81 billion$13.73 billionViewN/AView Earnings Details
4/29/2015Q115$2.54$2.47$13.51 billion$13.80 billionViewListenView Earnings Details
2/4/2015Q414$1.16$1.09$12.41 billion$12.23 millionViewListenView Earnings Details
11/7/2014Q314$2.01$1.85$12.34 billion$12.24 billionViewListenView Earnings Details
7/30/2014Q214$2.19$2.19$11.93 billion$12.22 billionViewListenView Earnings Details
5/7/2014Q114$1.94$2.35$11.45 billion$11.71 billionViewListenView Earnings Details
2/5/2014Q413$0.95($0.19)$10.23 billion$10.20 billionViewListenView Earnings Details
11/6/2013Q313$2.14$2.31$10.27 billion$10.00 billionViewListenView Earnings Details
7/31/2013Q2 2013$2.46$2.63$10.36 billion$10.32 billionViewListenView Earnings Details
5/1/2013Q1 2013$1.80$2.95$10.23 billion$10.49 billionViewListenView Earnings Details
2/4/2013Q4 2012$1.07$1.19$9.73 billion$9.56 billionViewListenView Earnings Details
11/5/2012Q312$2.05$2.62$9.86 billion$9.65 billionViewN/AView Earnings Details
7/30/2012$2.21$2.16ViewN/AView Earnings Details
4/30/2012$1.54$1.49ViewN/AView Earnings Details
2/6/2012$1.20$1.20ViewN/AView Earnings Details
10/31/2011$2.03$2.54ViewN/AView Earnings Details
8/1/2011$2.05$2.50ViewN/AView Earnings Details
5/2/2011$1.86$1.86ViewN/AView Earnings Details
2/7/2011$0.81$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Humana (NYSE:HUM) Earnings Estimates

2017 EPS Consensus Estimate: $10.79
2018 EPS Consensus Estimate: $12.12
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.07$2.75$2.36
Q2 20174$2.37$3.29$3.00
Q3 20174$3.18$3.44$3.30
Q4 20174$1.97$2.56$2.14
Q1 20182$2.64$2.72$2.68
Q2 20182$3.32$3.44$3.38
Q3 20182$3.38$3.48$3.43
Q4 20182$2.43$2.83$2.63
(Data provided by Zacks Investment Research)

Dividends

Humana (NYSE:HUM) Dividend Information

Next Dividend:1/26/2018
Annual Dividend:$1.60
Dividend Yield:0.63%
Dividend Growth:3.10% (3 Year Average)
Payout Ratio:12.59% (Trailing 12 Months of Earnings)
13.76% (Based on This Year's Estimates)
13.20% (Based on Next Year's Estimates)
Track Record:6 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Humana (NYSE:HUM)

Humana (NYSE:HUM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/2/2017quarterly$0.400.62%12/28/201712/29/20171/26/2018
8/17/2017$0.409/28/20179/29/201710/16/2017
8/17/2017quarterly$0.400.65%9/28/20178/29/201710/27/2017
4/20/2017quarterly$0.400.75%6/28/20176/30/20177/31/2017
2/15/2017quarterly$0.400.78%3/29/20173/31/20174/28/2017
10/26/2016quarterly$0.290.67%1/10/20171/12/20171/27/2017
8/25/2016quarterly$0.290.65%10/11/201610/13/201610/28/2016
4/21/2016quarterly$0.290.66%6/28/20166/30/20167/29/2016
2/18/2016quarterly$0.290.7%3/29/20163/31/20164/29/2016
10/29/2015quarterly$0.290.65%12/28/201512/30/20151/29/2016
8/27/2015quarterly$0.290.63%9/28/20159/30/201510/30/2015
4/17/2015quarterly$0.290.65%6/26/20156/30/20157/31/2015
2/18/2015quarterly$0.280.73%3/27/20153/31/20154/24/2015
10/31/2014quarterly$0.280.81%12/29/201412/31/20141/30/2015
8/27/2014quarterly$0.280.88%9/26/20149/30/201410/31/2014
4/30/2014quarterly$0.281.02%6/26/20146/30/20147/25/2014
2/19/2014quarterly$0.271.06%3/27/20143/31/20144/25/2014
10/30/2013quarterly$0.271.17%12/27/201312/31/20131/31/2014
8/22/2013quarterly$0.271.14%9/26/20139/30/201310/25/2013
4/25/2013quarterly$0.271.47%6/26/20136/28/20137/26/2013
2/27/2013quarterly$0.261.52%3/26/20133/28/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Humana (NYSE HUM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 94.19%
Insider Trades by Quarter for Humana (NYSE:HUM)
Institutional Ownership by Quarter for Humana (NYSE:HUM)

Humana (NYSE HUM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/1/2017Elizabeth D BierbowerInsiderSell9,786$259.00$2,534,574.00View SEC Filing  
9/1/2017Timothy S HuvalVPSell7,803$258.14$2,014,266.42View SEC Filing  
8/23/2017William Kevin FlemingInsiderSell3,071$250.98$770,759.58View SEC Filing  
8/11/2017Bruce D BroussardCEOSell12,000$251.88$3,022,560.00View SEC Filing  
8/10/2017M Todoroff ChristopherVPSell22,935$252.52$5,791,546.20View SEC Filing  
6/28/2017Brian P LeclaireSVPSell4,971$240.00$1,193,040.00View SEC Filing  
5/26/2017Heidi S MargulisVPSell1,500$231.96$347,940.00View SEC Filing  
5/5/2017Jody L BilneySVPSell4,600$230.16$1,058,736.00View SEC Filing  
5/4/2017Bruce D BroussardCEOSell118,231$225.82$26,698,924.42View SEC Filing  
5/4/2017Timothy S HuvalVPSell13,939$225.86$3,148,262.54View SEC Filing  
3/21/2017Jody L BilneySVPSell4,348$213.80$929,602.40View SEC Filing  
3/6/2017James E MurrayCOOSell31,151$213.62$6,654,476.62View SEC Filing  
3/3/2017Cynthia H ZipperleVPSell1,885$213.37$402,202.45View SEC Filing  
2/24/2017Brian P LeclaireSVPSell4,971$204.81$1,018,110.51View SEC Filing  
2/22/2017Brian P LeclaireSVPSell26,894$205.24$5,519,724.56View SEC Filing  
2/22/2017James E MurrayCOOSell9,523$204.69$1,949,262.87View SEC Filing  
2/22/2017Roy A BeveridgeVPSell4,832$205.73$994,087.36View SEC Filing  
2/21/2017Bruce D BroussardCEOSell104,256$205.23$21,396,458.88View SEC Filing  
2/21/2017Cynthia H ZipperleCAOSell4,213$204.67$862,274.71View SEC Filing  
2/21/2017David A. Jr/Ky JonesDirectorSell27,000$205.04$5,536,080.00View SEC Filing  
2/21/2017James E MurrayCOOSell70,332$205.20$14,432,126.40View SEC Filing  
2/21/2017Jody L BilneySVPSell6,087$204.72$1,246,130.64View SEC Filing  
2/21/2017M Todoroff ChristopherVPSell24,140$205.33$4,956,666.20View SEC Filing  
2/25/2016Brian P LeclaireSVPSell183$176.11$32,228.13View SEC Filing  
3/11/2015James E MurrayCOOSell35,220$160.90$5,666,898.00View SEC Filing  
3/2/2015Brian P LeclaireSVPSell5,500$161.79$889,845.00View SEC Filing  
2/25/2015Bruce D BroussardCEOSell41,105$165.29$6,794,245.45View SEC Filing  
2/25/2015David A Jr/Ky JonesDirectorSell6,100$165.39$1,008,879.00View SEC Filing  
2/24/2015Heidi S MargulisVPSell3,665$164.44$602,672.60View SEC Filing  
8/22/2014Brian P LeclaireSVPSell3,250$123.04$399,880.00View SEC Filing  
5/15/2014Heidi MargulisVPSell3,345$119.56$399,928.20View SEC Filing  
5/12/2014Marissa PetersonDirectorSell2,026$123.30$249,805.80View SEC Filing  
3/19/2014James MurrayCOOSell36,833$116.59$4,294,359.47View SEC Filing  
3/18/2014M Todoroff ChristopherVPSell8,000$113.20$905,600.00View SEC Filing  
3/13/2014Bruce BroussardCEOSell109,000$109.84$11,972,560.00View SEC Filing  
3/10/2014Webster Roy DunbarDirectorSell9,587$110.30$1,057,446.10View SEC Filing  
12/4/2013Marissa PetersonDirectorSell1,147$103.54$118,760.38View SEC Filing  
12/2/2013M Todoroff ChristopherVPSell6,000$105.50$633,000.00View SEC Filing  
11/26/2013Heidi MargulisVPSell5,500$104.42$574,310.00View SEC Filing  
11/8/2013David Jr/Ky JonesDirectorSell11,000$95.00$1,045,000.00View SEC Filing  
9/5/2013Elizabeth D BierbowerInsiderSell17,673$96.01$1,696,784.73View SEC Filing  
8/30/2013Heidi MargulisVPSell3,319$93.35$309,828.65View SEC Filing  
8/29/2013David Jr/Ky JonesDirectorSell2,500$93.01$232,525.00View SEC Filing  
8/23/2013Elizabeth BierbowerInsiderSell6,063$94.00$569,922.00View SEC Filing  
8/15/2013Michael MccallisterDirectorSell138,817$91.49$12,700,367.33View SEC Filing  
8/13/2013Bruce PerkinsInsiderSell9,000$93.47$841,230.00View SEC Filing  
8/8/2013Steven McculleyVPSell10,000$92.54$925,400.00View SEC Filing  
8/7/2013James BloemCFOSell33,000$91.79$3,029,070.00View SEC Filing  
8/1/2013M Todoroff ChristopherVPSell39,596$90.30$3,575,518.80View SEC Filing  
6/24/2013Paul B K KusserowSVPSell34,219$84.60$2,894,927.40View SEC Filing  
6/18/2013Elizabeth D BierbowerInsiderSell8,033$83.29$669,068.57View SEC Filing  
5/30/2013James E MurrayCOOSell11,000$81.96$901,560.00View SEC Filing  
5/9/2013Michael B MccallisterDirectorSell281,312$77.72$21,863,568.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Humana (NYSE HUM) News Headlines

Source:
DateHeadline
Humana (HUM) Board Declares Share Repurchase PlanHumana (HUM) Board Declares Share Repurchase Plan
www.americanbankingnews.com - December 15 at 11:14 AM
Moodys rates Humanas senior notes Baa3; outlook stableMoody's rates Humana's senior notes Baa3; outlook stable
www.moodys.com - December 15 at 9:06 AM
Humana expands stock buy-back program to $3 billionHumana expands stock buy-back program to $3 billion
www.bizjournals.com - December 14 at 3:28 PM
Humana Board Approves $3 Bln Share Repurchase Authorization - Quick FactsHumana Board Approves $3 Bln Share Repurchase Authorization - Quick Facts
www.nasdaq.com - December 14 at 3:28 PM
Humana to buy $3 billion of company stockHumana to buy $3 billion of company stock
finance.yahoo.com - December 14 at 3:28 PM
Humana Inc. -- Moodys rates Humanas senior notes Baa3; outlook stableHumana Inc. -- Moody's rates Humana's senior notes Baa3; outlook stable
finance.yahoo.com - December 14 at 3:28 PM
Humana Announces $3 Billion Share Repurchase Authorization - Business Wire (press release)Humana Announces $3 Billion Share Repurchase Authorization - Business Wire (press release)
www.businesswire.com - December 14 at 9:01 AM
Humana (HUM) Receives "Buy" Rating from CowenHumana (HUM) Receives "Buy" Rating from Cowen
www.americanbankingnews.com - December 13 at 6:22 PM
ETFs with exposure to Humana, Inc. : December 13, 2017ETFs with exposure to Humana, Inc. : December 13, 2017
finance.yahoo.com - December 13 at 3:28 PM
Zacks: Analysts Expect Humana Inc (HUM) Will Announce Quarterly Sales of $13.02 BillionZacks: Analysts Expect Humana Inc (HUM) Will Announce Quarterly Sales of $13.02 Billion
www.americanbankingnews.com - December 13 at 2:50 PM
Humana (HUM) a Buy on High-Level Earnings GrowthHumana (HUM) a Buy on High-Level Earnings Growth
investorplace.com - December 13 at 2:29 PM
Humana, Inc. :HUM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 12, 2017Humana, Inc. :HUM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 12, 2017
finance.yahoo.com - December 12 at 3:27 PM
Humana Inc (HUM) Receives Consensus Rating of "Hold" from BrokeragesHumana Inc (HUM) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - December 11 at 8:14 AM
$2.00 EPS Expected for Humana Inc (HUM) This Quarter$2.00 EPS Expected for Humana Inc (HUM) This Quarter
www.americanbankingnews.com - December 11 at 1:24 AM
8 things you need to know this morning - Baltimore Business Journal - Baltimore Business Journal8 things you need to know this morning - Baltimore Business Journal - Baltimore Business Journal
www.bizjournals.com - December 8 at 3:27 PM
Cantor Fitzgerald Weighs in on Humana Incs FY2018 Earnings (HUM)Cantor Fitzgerald Weighs in on Humana Inc's FY2018 Earnings (HUM)
www.americanbankingnews.com - December 8 at 12:10 PM
Humana Inc (HUM) to Post Q2 2018 Earnings of $3.32 Per Share, Jefferies Group ForecastsHumana Inc (HUM) to Post Q2 2018 Earnings of $3.32 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - December 8 at 9:28 AM
Stock Review for Health Care Plans Investors -- CVS Health, Molina Healthcare, UnitedHealth, and Humana - PR Newswire (press release)Stock Review for Health Care Plans Investors -- CVS Health, Molina Healthcare, UnitedHealth, and Humana - PR Newswire (press release)
www.prnewswire.com - December 7 at 9:09 AM
CVS-Aetna deal could expedite a possible Humana merger - Louisville Business FirstCVS-Aetna deal could expedite a possible Humana merger - Louisville Business First
www.bizjournals.com - December 6 at 3:27 PM
Renew Recovery Providing Opioid Addiction Services to Humana Members in Kentucky - Business Wire (press release)Renew Recovery Providing Opioid Addiction Services to Humana Members in Kentucky - Business Wire (press release)
www.businesswire.com - December 6 at 3:27 PM
New Humana Tool Aims to Improve Medication Management and Safety - Business Wire (press release)New Humana Tool Aims to Improve Medication Management and Safety - Business Wire (press release)
www.businesswire.com - December 6 at 3:27 PM
New Humana Tool Aims to Improve Medication Management and SafetyNew Humana Tool Aims to Improve Medication Management and Safety
finance.yahoo.com - December 6 at 3:27 PM
Humana (HUM) Given Hold Rating at Cantor FitzgeraldHumana (HUM) Given Hold Rating at Cantor Fitzgerald
www.americanbankingnews.com - December 6 at 2:56 PM
Earnings Growth Make Humana (HUM) a BuyEarnings Growth Make Humana (HUM) a Buy
investorplace.com - December 6 at 1:44 PM
Why CVS/Aetna Could Be a Game Changer -- Who Sells Out Next May Shock YouWhy CVS/Aetna Could Be a Game Changer -- Who Sells Out Next May Shock You
finance.yahoo.com - December 5 at 3:27 PM
Humana Partners Einstein Healthcare for Value-Based CareHumana Partners Einstein Healthcare for Value-Based Care
www.zacks.com - December 4 at 9:08 AM
CVS Is Said to Buy Aetna for $67.5 Billion, Remaking Sector - BloombergCVS Is Said to Buy Aetna for $67.5 Billion, Remaking Sector - Bloomberg
www.bloomberg.com - December 3 at 3:27 PM
Einstein, Humana expand their network provider agreement - Philadelphia Business JournalEinstein, Humana expand their network provider agreement - Philadelphia Business Journal
www.bizjournals.com - December 2 at 3:26 PM
Einstein Healthcare Network and Humana Team Up to Offer a Better Patient Experience in Southeastern Pennsylvania ... - Business Wire (press release)Einstein Healthcare Network and Humana Team Up to Offer a Better Patient Experience in Southeastern Pennsylvania ... - Business Wire (press release)
www.businesswire.com - December 1 at 11:46 AM
A CVS-Aetna deal could force Wal-Mart to buy Humana, analyst saysA CVS-Aetna deal could force Wal-Mart to buy Humana, analyst says
finance.yahoo.com - December 1 at 11:46 AM
Einstein Healthcare Network and Humana Team Up to Offer a Better Patient Experience in Southeastern Pennsylvania for Humana Medicare Advantage MembersEinstein Healthcare Network and Humana Team Up to Offer a Better Patient Experience in Southeastern Pennsylvania for Humana Medicare Advantage Members
finance.yahoo.com - November 30 at 3:27 PM
Humana’s (HUM) Robust Earnings Momentum Make it a BuyHumana’s (HUM) Robust Earnings Momentum Make it a Buy
investorplace.com - November 30 at 9:10 AM
Traders Buy Large Volume of Call Options on Humana (HUM)Traders Buy Large Volume of Call Options on Humana (HUM)
www.americanbankingnews.com - November 30 at 5:16 AM
Pete Najarian Sees Unusual Options Activity In HumanaPete Najarian Sees Unusual Options Activity In Humana
www.benzinga.com - November 29 at 3:26 PM
Study Details Growing Acceptance of Value-based Payments Among Family Physicians, but Barriers Still ExistStudy Details Growing Acceptance of Value-based Payments Among Family Physicians, but Barriers Still Exist
finance.yahoo.com - November 29 at 3:26 PM
Humana’s (HUM) Robust Earnings Momentum Make it a BuyHumana’s (HUM) Robust Earnings Momentum Make it a Buy
investorplace.com - November 29 at 2:48 PM
Humana and CHI Franciscan Health Team Up to Create a Quality ... - Business Wire (press release)Humana and CHI Franciscan Health Team Up to Create a Quality ... - Business Wire (press release)
www.businesswire.com - November 29 at 9:10 AM
In New National Survey, Socially Engaged Older Americans Report Higher Levels of Good HealthIn New National Survey, Socially Engaged Older Americans Report Higher Levels of Good Health
finance.yahoo.com - November 28 at 3:26 PM
Humanas Medicare Business Impresses, Public Exchange HurtsHumana's Medicare Business Impresses, Public Exchange Hurts
finance.yahoo.com - November 27 at 5:29 PM
From Wal-Mart to Walgreens, Humana Could Have Its Pick of SuitorsFrom Wal-Mart to Walgreens, Humana Could Have Its Pick of Suitors
finance.yahoo.com - November 27 at 5:29 PM
Bulls make a big bet on HumanaBulls make a big bet on Humana
finance.yahoo.com - November 27 at 5:29 PM
 Brokerages Expect Humana Inc. (HUM) Will Post Quarterly Sales of $13.02 Billion Brokerages Expect Humana Inc. (HUM) Will Post Quarterly Sales of $13.02 Billion
www.americanbankingnews.com - November 25 at 9:04 AM
Video: Why balancing digital strategy with digital maturity is key for innovation at HumanaVideo: Why balancing digital strategy with digital maturity is key for innovation at Humana
finance.yahoo.com - November 24 at 10:07 AM
 Analysts Expect Humana Inc. (HUM) Will Post Earnings of $2.00 Per Share Analysts Expect Humana Inc. (HUM) Will Post Earnings of $2.00 Per Share
www.americanbankingnews.com - November 23 at 3:10 AM
Earnings Growth Keep Humana (HUM) a BuyEarnings Growth Keep Humana (HUM) a Buy
investorplace.com - November 22 at 2:25 PM
Humana’s (HUM) Quant Score Makes it BuyHumana’s (HUM) Quant Score Makes it Buy
investorplace.com - November 17 at 6:08 PM
The Zacks Analyst Blog Highlights: TOTAL S.A., Humana, Novo Nordisk, Target and XcelThe Zacks Analyst Blog Highlights: TOTAL S.A., Humana, Novo Nordisk, Target and Xcel
finance.yahoo.com - November 17 at 6:08 PM
Top Analyst Reports for TOTAL S.A., Humana & Novo NordiskTop Analyst Reports for TOTAL S.A., Humana & Novo Nordisk
finance.yahoo.com - November 17 at 8:11 AM
As Humana Moves Doctors To Value-Based Pay, Medicare Costs Fall - ForbesAs Humana Moves Doctors To Value-Based Pay, Medicare Costs Fall - Forbes
www.forbes.com - November 16 at 5:49 PM
Oscar Health Finances Improve Ahead Of Obamacare ExpansionOscar Health Finances Improve Ahead Of Obamacare Expansion
finance.yahoo.com - November 16 at 5:49 PM

SEC Filings

Humana (NYSE:HUM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Humana (NYSE:HUM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Humana (NYSE HUM) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.